Event Date/Time: Nov 16, 2005
End Date/Time: Nov 17, 2005
IBC’s Transmissible Spongiform Encephalopathies (TSEs) meeting offers scientists working in biopharmaceutical production and blood/tissue products a focused look at the information needed for the development of risk assessment plans and controls procedures. By attending, you’ll hear scientific updates to further your understanding of prion-proteins and help you track progress on the development of diagnostic tests to improve the quality and cost of monitoring TSE infectivity. The event offers presentations on industry best practices, case studies from leading researchers and FDA regulatory updates to help you assess your readiness to confront potential problems. Plus, attend IBC’s co-located Viral Safety conferences for the latest strategies for viral detection, removal and validation – along with FDA regulatory perspectives. For further details and to register, visit: http://www.IBCLifeSciences.com/TSE or call +1 (508) 616-5550.